patients with complicated appendicitis, 173 (42.3%) were identified as having a serum sodium level of less than 135 mEq/L (to convert to millimoles per liter, multiply by 1.0). Longer hospital lengths of stay, deep surgical site infections, and return visits to the emergency department were more prevalent among patients with complicated appendicitis.
Discussion | Complicated appendicitis is associated with poor outcomes, and its early identification may have implications for patient management, specifically with regard to the timing of operative intervention and the appropriateness of nonoperative management strategies. The finding of hyponatremia at admission may help distinguish necrotizing soft-tissue infections from nonnecrotizing soft-tissue infections 2 and is a known risk factor for mortality among patients presenting with necrotizing soft-tissue infections. 3 Hyponatremia at admission is also predictive of gangrenous cholecystitis and, more recently, has been associated with perforated colonic pathology among elderly patients who underwent emergency general surgery. 4, 5 The etiology for hyponatremia in patients with advanced surgical infectious pathology, including complicated appendicitis, is unknown but is likely an antidiuretic hormonemediated phenomenon. Whether the increase in antidiuretic hormones is appropriate or inappropriate, however, remains to be elucidated. Future investigations accounting for the clinical volume status and key determinants of serum sodium concentration are potentially warranted.
Our study is limited by its retrospective design and lack of data regarding the etiology of hyponatremia in patients with complicated appendicitis. Also, we did not examine all the variables potentially associated with complicated appendicitis; however, the main objective of our study was to analyze readily available and routinely ordered data used in the workup of adult patients with suspected acute appendicitis.
In the appropriate clinical context, hyponatremia in patients with acute appendicitis may be suggestive of complicated appendicitis. Prospective studies are required to confirm this finding and to determine the potential effect of an earlier operative intervention on outcomes. 
Preventability of Hospital-Acquired Venous Thromboembolism
Venous thromboembolism (VTE) is a common, largely preventable condition. The Agency for Healthcare Research and Quality reports that VTE prophylaxis is among the top-10 strongly suggested practices for improving patient safety.
1 Although optimal VTE prevention requires both prescription and administration of prophylactic medications, to date, most attempts to improve care have focused predominantly on medication prescription.
2 Copyright 2015 American Medical Association. All rights reserved.
National bodies (eg, the Centers for Medicare and Medicaid Services) and regional entities (eg, the Maryland Health Services Cost Review Commission) impose financial penalties for hospitalized patients developing VTE despite evidence that not all events are preventable, even with prophylaxis. 3 Publicly reported measures from both The Joint Commission's Core Measures and the Centers for Medicare and Medicaid Services' Hospital Compare report whether a patient received at least 1 dose of VTE prophylaxis within the first day of hospitalization, rather than considering all prescribed and administered doses for the entire hospitalization. 4 Current measures for the quality of VTE care provide limited insights into the extent to which VTE is preventable. The specific aim of our study was to characterize the true preventability of VTE by identifying the proportion of patients with VTE who had received "defect-free care."
Methods | We conducted a retrospective review of patients with hospital-acquired VTE identified by the Maryland Hospital Acquired Conditions pay-for-performance initiative at the Johns Hopkins Hospital for 1 year (July 2010-June 2011). Our study was approved by the institutional review board of the Johns Hopkins University School of Medicine under a waiver of consent. Data on patient risk assessment for VTE (using our mandatory computerized clinical decision support tool), prescription of risk-appropriate prophylaxis, 5 and pharmacological prophylaxis administration were abstracted from the electronic health record. Because catheter-associated deep vein thrombosis (DVT) is not preventable with prophylaxis, 6 we excluded patients with upper extremity, catheter-associated DVT. The remaining patients were dichotomized by whether or not they received defect-free care, which is defined as receiving all doses of risk-appropriate VTE prophylaxis as recommended by our validated, mandatory computerized clinical decision support tool 5 prior to VTE diagnosis. Suboptimal care was further classified as prescription failures or dose-administration failures. We counted patients with a documented contraindication to pharmacologic prophylaxis (n = 6) who were prescribed sequential compression devices as defectfree care. We compared characteristics between groups using a 2-sided χ 2 test, an unpaired t test, or the Wilcoxon rank sum test using Stata version 12.0 (StataCorp).
Results | A total of 128 patients had hospital-acquired VTE. Of these 128 patients, 36 (28%) had nonpreventable, catheterrelated DVT, leaving 92 patients (72%) who experienced VTE events (45 had DVT only, 43 had a pulmonary embolism only, and 4 had both DVT and a pulmonary embolism) that were potentially preventable with prophylaxis (Table) . Of the 92 patients who experienced VTE events, 79 (86%) were prescribed optimal prophylaxis, yet only 43 (47%) received defect-free care. Of the 49 patients (53%) who received suboptimal care, 13 (27%) were not prescribed risk-appropriate VTE prophylaxis, and 36 (73%) missed at least 1 dose of appropriately prescribed prophylaxis (Figure) . There was no difference in suboptimal care patterns between surgical and medical patients.
Discussion | Our study identifies a need to dramatically reevaluate the VTE outcome and process measures. Half of VTE events identified in a state-run pay-for-performance program were not truly preventable because patients received best-practice prevention, and there was no real opportunity for improvement. Venous thromboembolism outcome measures should not include these patients as having "potentially preventable events." The overwhelming cause (73%) of inadequate VTE prophylaxis was patients missing at least 1 medication dose, which is associated with VTE events. 7 Until recently, the importance of missed VTE prophylaxis doses has been underappreciated. Perhaps targeting missed doses will have a significant effect on VTE events. The current The Joint Commission/Centers for Medicare and Medicaid Services sampling method was likely adopted to reduce the burden of data collection. Our study questions the validity of this approach, which misclassifies suboptimal care as high-quality care, misinforms the public, and may limit efforts by health care professionals to improve VTE prevention when they already score well on these misleading measures. To reduce preventable harm, policy makers need to improve the measures, and clinicians need to ensure that patients receive all prescribed preventative therapies. 8 As electronic health records are adopted nationally, information technology will allow us to use more advanced clinical analytics to base VTE process measures on every dose of VTE prophylaxis for every hospitalized patient. 
